According to Bild, Bayern Munich has revealed that Musiala's current treatment plan has been adjusted. Bild interviewed Professor Christoph Kleinschnitz, head of the Neurology Department at Essen University Hospital, about how patients with absence epilepsy typically adjust their medication. Kleinschnitz stated that anti-epileptic drugs cannot be stopped abruptly and that during the medication transition phase, seizure frequency may increase.

Bild asked: "In general, what process do patients with absence epilepsy typically follow when changing medications?"

Christoph Kleinschnitz stated: "Anti-epileptic drugs cannot be stopped abruptly. This means the previously used medication must be gradually reduced until discontinuation, while the dose of the new medication is gradually increased. During this transition phase, seizures may become more frequent because the new medication's effectiveness has not yet fully taken hold."

Bild asked: "Why is it necessary to adjust medication?"

Christoph Kleinschnitz stated: "There could be multiple reasons. For example, the previously used medication may have lost its effectiveness, or the side effects are too severe, such as causing dizziness, fatigue, and concentration or memory problems. Weight gain could also be one of the factors."

Bild continued: "Eberl has acknowledged that Musiala has been experiencing absence seizures during the last season. Does this surprise you?"

Christoph Kleinschnitz stated: "No. This only indicates that his condition has been well-controlled. Furthermore, even in such cases, patients can still engage in high-level competitive sports. This could also explain why Musiala has not returned to his previous level after suffering a serious injury. I hope he can recover it soon."

Traducido por IA.

¡El sitio web de AF ya está disponible! Consulta noticias, comentarios, detalles de partidos y estadísticas en tu ordenador. Visita: www.allfootballapp.com